| 注册
首页|期刊导航|北京中医药|乌鸡白凤丸治疗慢性肾脏病合并高尿酸血症患者的临床观察

乌鸡白凤丸治疗慢性肾脏病合并高尿酸血症患者的临床观察

梁毓恬 饶向荣 郭传 廖熠蕾 陈枭龙 方雅炫 王子贤 方吕贵 张南南 严玉萍

北京中医药2025,Vol.44Issue(9):1111-1114,4.
北京中医药2025,Vol.44Issue(9):1111-1114,4.DOI:10.16025/j.1674-1307.2025.09.005

乌鸡白凤丸治疗慢性肾脏病合并高尿酸血症患者的临床观察

Clinical efficacy of Wuji Baifeng Pills in the treatment of patients with hyperuricemia complicated by chronic kidney disease

梁毓恬 1饶向荣 1郭传 1廖熠蕾 1陈枭龙 1方雅炫 1王子贤 1方吕贵 2张南南 3严玉萍4

作者信息

  • 1. 中国中医科学院广安门医院肾病科,北京 100053
  • 2. 中国中医科学院广安门医院南区肾病科,北京 102600
  • 3. 北京中医药大学房山医院肾病科,北京 102400
  • 4. 北京同仁堂股份有限公司科学研究所,北京 100011
  • 折叠

摘要

Abstract

Objective To observe the effects of Wuji Baifeng Pills on serum uric acid(SUA)levels and estimated glomerular filtration rate(eGFR)in patients with chronic kidney disease(CKD)stages 2~4 complicated by hyperuricemia(HUA).Methods A total of 140 patients with CKD stages 2~4 complicated by HUA treated.Patients were randomly assigned using computer-generated randomization.During the study,13 patients dropped out and 8 were excluded,leaving 59 patients in the treatment group and 60 in the control group.The control group received general lifestyle interventions and standard basic treatment,while the treatment group additionally received Wuji Baifeng Pills orally(1 pill per time,twice daily).Both groups were treated continuously for 12 weeks.SUA,serum creatinine(SCr),eGFR,and traditional Chinese medicine(TCM)syndrome scores were measured before and after treatment.Results During the study,13 cases dropped out and 8 were excluded.Ultimately,59 cases remained in the treatment group and 60 in the control group.After 12 weeks of treatment,the SUA level in the Wuji Baifeng Pills group was significantly lower than that in the control group(P<0.05),and the within-group comparison before and after treatment also showed a statistically significant difference(P<0.05).SCr and eGFR in the treatment group showed significant improvement compared to before treatment(P<0.05).TCM syndrome scores and main symptom scores improved in both groups(P<0.05).No patients required dialysis during the study.Three cases in the treatment group had mildly elevated transaminase levels.Conclusion Wuji Baifeng Pills can effectively reduce SUA levels,improve related clinical symptoms and renal function indicators in patients with CKD stages 2~4 complicated by HUA(patterned as spleen-kidney deficiency with blood deficiency and blood stasis),with a good safety profile.

关键词

乌鸡白凤丸/慢性肾脏病/高尿酸血症/脾肾亏虚,血虚血瘀/随机对照试验

Key words

Wuji Baifeng Pills/chronic kidney disease/hyperuricemia/spleen-kidney deficiency/blood deficiency and blood stasis/randomized controlled trial

引用本文复制引用

梁毓恬,饶向荣,郭传,廖熠蕾,陈枭龙,方雅炫,王子贤,方吕贵,张南南,严玉萍..乌鸡白凤丸治疗慢性肾脏病合并高尿酸血症患者的临床观察[J].北京中医药,2025,44(9):1111-1114,4.

基金项目

北京市科技计划医药创新品种及平台培育专项(Z241100009024041) (Z241100009024041)

北京中医药

1674-1307

访问量0
|
下载量0
段落导航相关论文